Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
- Not stated
- Not stated
- Oct 13, 2026
Official announcement on Grants.gov · opens the funder's page. Always confirm dates there.
Summary
The purpose of this notice of funding opportunity (NOFO) is to support research and/or preclinical development of highly efficacious vaccines against malaria - one of the deadliest mosquito-borne diseases - by capitalizing on recent technological innovations, particularly in structure-based immunogen design, improved formulations, and…
Preparing an application?
On Plus, $39 a month
- The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
More from National Institutes of Health
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
$500k
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
$2.3M
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
$1.3M